| scholarly article | Q13442814 |
| P50 | author | Frank H Duffy | Q89442215 |
| P2093 | author name string | Frank Hamilton | |
| Kenneth L Koch | |||
| Gianrico Farrugia | |||
| Linda Lee | |||
| Thomas L Abell | |||
| William L Hasler | |||
| James Tonascia | |||
| Henry P Parkman | |||
| Pankaj J Pasricha | |||
| Aynur Unalp-Arida | |||
| Richard W McCallum | |||
| Katherine P Yates | |||
| William J Snape | |||
| Carol Rees Parrish | |||
| Jorge Calles | |||
| NIDDK Gastroparesis Clinical Research Consortium | |||
| Dorothy Petito | |||
| Linda Nguyan | |||
| P2860 | cites work | A reduced dietary questionnaire: development and validation | Q70254360 |
| Use of adjustment factors with a brief food frequency questionnaire to obtain nutrient values | Q70254408 | ||
| Assessment of gastric emptying using a low fat meal: establishment of international control values | Q73999675 | ||
| Comparison of food frequency questionnaires: the reduced Block and Willett questionnaires differ in ranking on nutrient intakes | Q77731126 | ||
| Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms | Q80057913 | ||
| Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders | Q81274132 | ||
| Obesity is an independent risk factor for GERD symptoms and erosive esophagitis | Q81805192 | ||
| Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
| Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids | Q29614194 | ||
| Nutrition concerns for the patient with gastroparesis | Q30444574 | ||
| Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting | Q33941371 | ||
| A data-based approach to diet questionnaire design and testing | Q34189078 | ||
| Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers | Q35597130 | ||
| Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations | Q35758442 | ||
| American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis | Q35936586 | ||
| Nutrition aspects of gastroparesis and therapies for drug-refractory patients | Q36378737 | ||
| Treatment of gastroparesis: a multidisciplinary clinical review | Q36428532 | ||
| Clinical practice. Diabetic gastroparesis | Q36741788 | ||
| Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine | Q37009041 | ||
| Dietary patterns and the risk of Barrett's esophagus | Q42032167 | ||
| Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. | Q51947880 | ||
| Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. | Q54255594 | ||
| Idiopathic gastroparesis is associated with a multiplicity of severe dietary deficiencies | Q70133276 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 486-98, 498.e1-7 | |
| P577 | publication date | 2011-04-28 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis | |
| P478 | volume | 141 |
| Q47189184 | A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial |
| Q37656120 | Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes |
| Q35824597 | Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods |
| Q45946784 | Bodyweight in patients with idiopathic gastroparesis: roles of symptoms, caloric intake, physical activity, and body metabolism. |
| Q90737893 | Botulinum Toxin A Improves Symptoms of Gastroparesis |
| Q38815458 | Chronic nausea and vomiting: insights into underlying mechanisms |
| Q34034345 | Clinical guideline: management of gastroparesis |
| Q53083035 | Diabetes and the Stomach. |
| Q63987568 | Diabetic Gastroparesis: Principles and Current Trends in Management |
| Q57491893 | Diabetic gastroparesis: current challenges and future prospects |
| Q38257887 | Dietary strategies for adult type 1 diabetes in light of outcome evidence |
| Q41562785 | Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis |
| Q39152502 | Effectiveness and feasibility of robotic gastric neurostimulator placement in patients with refractory gastroparesis. |
| Q34412103 | Emerging drugs for the treatment of gastroparesis |
| Q39195921 | End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis |
| Q88451013 | Endoscopic Therapies for Gastroparesis |
| Q41117151 | Foods provoking and alleviating symptoms in gastroparesis: patient experiences |
| Q50082095 | Galanin enhances systemic glucose metabolism through enteric Nitric Oxide Synthase-expressed neurons |
| Q37384029 | Gastric dysmotility and low serum vitamin D levels in patients with gastroparesis |
| Q38271037 | Gastric emptying and glycaemia in health and diabetes mellitus |
| Q92290635 | Gastroparesis and Dumping Syndrome: Current Concepts and Management |
| Q90347934 | Gastroparesis: a turning point in understanding and treatment |
| Q26998965 | Gastroparesis: concepts, controversies, and challenges |
| Q38116759 | Gastroparesis: from concepts to management |
| Q37902510 | Gastroparesis: pathogenesis, diagnosis and management |
| Q37102057 | Human and Murine Tissue-Engineered Colon Exhibit Diverse Neuronal Subtypes and Can Be Populated by Enteric Nervous System Progenitor Cells When Donor Colon Is Aganglionic. |
| Q26823475 | Idiopathic gastroparesis |
| Q47766771 | Management of gastroparesis-associated malnutrition. |
| Q38662831 | Novel insights into the effects of diabetes on gastric motility |
| Q100680816 | Nutritional approaches for gastroparesis |
| Q36328386 | Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis |
| Q58554835 | Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects |
| Q93062950 | Pathophysiology and management of diabetic gastroenteropathy |
| Q48073566 | Prevalence and predictors of delayed gastric emptying among Indian patients with long-standing type 2 diabetes mellitus |
| Q38824944 | Recommending Small, Frequent Meals in the Clinical Care of Adults: A Review of the Evidence and Important Considerations. |
| Q39150802 | Relamorelin for the treatment of gastrointestinal motility disorders |
| Q49495529 | Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry |
| Q40969264 | Taste and Smell Disturbances in Patients with Gastroparesis and Gastroesophageal Reflux Disease |
| Q38587559 | The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease. |
| Q38658415 | Treatment of gastrointestinal autonomic neuropathy |
| Q52923831 | Upper GI Disorders: Pathophysiology and Current Therapeutic Approaches. |
| Q37204670 | What are the important subsets of gastroparesis? |
Search more.